Lipofen is a drug owned by Cipher Pharmaceuticals Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jan 10, 2015. Details of Lipofen's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5545628 | Pharmaceutical composition containing fenofibrate |
Jan, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Lipofen is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Lipofen's family patents as well as insights into ongoing legal events on those patents.
Lipofen's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Lipofen's generic launch date based on the expiry of its last outstanding patent is estimated to be Jan 10, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Lipofen Generic API suppliers:
Fenofibrate is the generic name for the brand Lipofen. 33 different companies have already filed for the generic of Lipofen, with Rising having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Lipofen's generic
Alternative Brands for Lipofen
Lipofen which is used for managing high levels of cholesterol and triglycerides in the blood., has several other brand drugs using the same active ingredient (Fenofibrate). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | ||
|---|---|---|---|
| Abbvie |
| ||
| Lupin |
| ||
| Salix |
| ||
| Skyepharma Ag |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Fenofibrate, Lipofen's active ingredient. Check the complete list of approved generic manufacturers for Lipofen
About Lipofen
Lipofen is a drug owned by Cipher Pharmaceuticals Inc. It is used for managing high levels of cholesterol and triglycerides in the blood. Lipofen uses Fenofibrate as an active ingredient. Lipofen was launched by Cipher Pharms Inc in 2006.
Approval Date:
Lipofen was approved by FDA for market use on 11 January, 2006.
Active Ingredient:
Lipofen uses Fenofibrate as the active ingredient. Check out other Drugs and Companies using Fenofibrate ingredient
Treatment:
Lipofen is used for managing high levels of cholesterol and triglycerides in the blood.
Dosage:
Lipofen is available in capsule form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 50MG | CAPSULE | Prescription | ORAL |
| 100MG | CAPSULE | Discontinued | ORAL |
| 150MG | CAPSULE | Prescription | ORAL |